Compare iShares MSCI China ETF (MCHI) vs UiPath Inc (PATH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI China ETF vs UiPath Inc — how do they compare? iShares MSCI China ETF trades at $55.14, while UiPath Inc trades at $15.03 (market cap $8.14B). The key difference: UiPath Inc is trading nearer its 52-week high, iShares MSCI China ETF nearer its low. Which is the better fit depends on your goals.
| MCHI | PATH | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $66.99 | $19.29 |
52-Week Low | $50.48 | $9.38 |
Market Cap | — | $8.14B |
Enterprise Value | — | $6.92B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MCHI, the iShares MSCI China ETF, trades at $55.2, down 3.04% over the past day. Technical indicators show a bullish overall signal with strong moving average support, while oscillators are neutral. The ETF is positioned near key support at $55. Recent news highlights China's strong export growth, particularly in AI and tech sectors, and institutional interest, though some funds have reduced holdings. A dividend of $0.36 per share is scheduled for payment in June 2026.
The outlook for MCHI is cautiously optimistic, driven by China's robust export performance and tech sector strength, but tempered by geopolitical tensions and regulatory risks. Investment opportunities include exposure to undervalued Chinese equities and AI-driven growth, while risks involve U.S.-China trade friction and potential economic slowdowns. Investors should weigh these factors against the ETF's current technical strength.
PATH trades at $15.59, up 3.59% today, with a bullish technical signal from moving averages but overbought RSI readings. Revenue has grown from $892M in 2022 to $1.43B in 2025, with net losses narrowing significantly. Recent news highlights institutional stake increases and AI-driven rallies, while Q1 2026 EPS missed expectations.
The outlook is mixed: strong revenue growth and path to profitability by 2026 present opportunity, but high valuation ratios and competitive AI threats pose risks. Analyst consensus is cautious with a $13.33 price target below current levels, suggesting limited near-term upside amid execution uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares MSCI China ETF
MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →About UiPath Inc
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →
